Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000729263 | SCV000856910 | uncertain significance | not provided | 2017-09-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000729263 | SCV001083000 | benign | not provided | 2024-03-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003420291 | SCV004115655 | uncertain significance | ABCB11-related disorder | 2023-07-13 | criteria provided, single submitter | clinical testing | The ABCB11 c.3214-6C>G variant is predicted to interfere with splicing. This variant has been previously reported in the compound heterozygous state in an individual with progressive intrahepatic cholestasis (Table 1, Liu et al. 2010. PubMed ID: 19845854). This variant is reported in 0.23% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-169787378-G-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |